SLRN Acelyrin Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: SLRN

Price (delayed)

$5.01

Market cap

$492.81M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$5.43

Enterprise value

$275.91M

Highlights
The EPS has surged by 87% year-on-year and by 73% since the previous quarter
Acelyrin's debt has decreased by 4.6% from the previous quarter
SLRN's quick ratio has shrunk by 57% YoY and by 28% QoQ
SLRN's net income is down by 25% since the previous quarter
Sector: Healthcare
Industry: Biotechnology
Peers: OCX OGEN OLMA OMER

Key stats

What are the main financial stats of SLRN
Market
Shares outstanding
98.37M
Market cap
$492.81M
Enterprise value
$275.91M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
0.74
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Earnings
Revenue
$0
EBIT
-$381.64M
EBITDA
-$381.37M
Free cash flow
-$172M
Per share
EPS
-$5.43
Free cash flow per share
-$2.45
Book value per share
$6.74
Revenue per share
$0
TBVPS
$10.57
Balance sheet
Total assets
$742.69M
Total liabilities
$86.35M
Debt
$1.19M
Equity
$656.34M
Working capital
$651.48M
Liquidity
Debt to equity
0
Current ratio
8.65
Quick ratio
8.47
Net debt/EBITDA
0.57
Margins
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Efficiency
Return on assets
-57%
Return on equity
-74.6%
Return on invested capital
-149.9%
Return on capital employed
-58%
Return on sales
N/A
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

SLRN stock price

How has the Acelyrin stock price performed over time
Intraday
2.66%
1 week
-6.7%
1 month
-37.06%
1 year
N/A
YTD
-32.84%
QTD
-25.78%

Financial performance

How have Acelyrin's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$422.06M
Net income
-$381.64M
Gross margin
N/A
Net margin
N/A
SLRN's net income is down by 25% since the previous quarter
Acelyrin's operating income has decreased by 24% QoQ

Growth

What is Acelyrin's growth rate over time

Valuation

What is Acelyrin stock price valuation
P/E
N/A
P/B
0.74
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
The EPS has surged by 87% year-on-year and by 73% since the previous quarter
SLRN's equity is down by 10% since the previous quarter

Efficiency

How efficient is Acelyrin business performance
SLRN's return on assets has dropped by 86% year-on-year and by 5% since the previous quarter
Acelyrin's return on invested capital has surged by 71% YoY and by 25% QoQ
Acelyrin's return on equity has increased by 22% QoQ

Dividends

What is SLRN's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for SLRN.

Financial health

How did Acelyrin financials performed over time
Acelyrin's total assets has soared by 132% YoY but it has decreased by 7% from the previous quarter
SLRN's quick ratio has shrunk by 57% YoY and by 28% QoQ
Acelyrin's debt is 100% less than its equity
SLRN's equity is down by 10% since the previous quarter
Acelyrin's debt has decreased by 4.6% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.